[{"arm_notes": "", "treatment_id": null, "treatment_name": "A nebulized aerosol dose of sodium heparin 25;000 IU (1mL) diluted with 4 mL of 0.9% saline will be administered through a vibrating mesh nebulizer to 50 patients hospitalized with COVID-19. Another 50 patients receiving standard care will be observed to comprise the control arm. Inflammatory biomarkers will be evaluated on days 1; 8; 15 and 29 for comparison between groups.;B34.2", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 873, "treatment_name": "Nebulised unfractionated heparin (ufh)", "treatment_type": "Coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]